BusinessNeutriSci and Lexaria Bioscience Enter Global Licensing AgreementBy Nasdaq OMXFeb 26, 2018, 1:30 PM UTC
BusinessYield10 Bioscience Grants Research License to Monsanto to Evaluate Two Novel Yield Traits in SoybeanBy Nasdaq OMXDec 11, 2017, 1:00 PM UTC
BusinessPathway Health Announces Exclusive INTERACT® License AgreementBy Nasdaq OMXOct 18, 2016, 1:01 PM UTC
BusinessPathway Health Announces Exclusive INTERACT® License AgreementBy Nasdaq OMXOct 18, 2016, 1:01 PM UTC
BusinessRhizen Pharmaceuticals Announces Exclusive Worldwide License Agreement for the Development and Commercialization of a Dual PI3K-delta gamma InhibitorBy Nasdaq OMXDec 9, 2015, 12:00 PM UTC
